in this NPR Op-Ed, Josh Eibelman '20 describes how millions of individuals suffering from Alzheimers that are not fluent in English are barred from participating in clinical trials to treat Alzheimers.
"According to interviews with doctors, government officials and pharmaceutical companies, few Alzheimer's studies include medical interpreters to help patients complete the specialized neuropsychological testing component required," Eibelman writes.
Continue reading the full article on the NPR website.
More News from A&S
Joe Wilensky/Cornellians
Cornell scrapbooks created by students in the First American University, a one-credit American Studies course
Ryan Young/Cornell University
Semiconductors are at the core of the economy and national security. Their importance makes them a target. Sarah Kreps, director of the Tech Policy Institute in the Cornell Jeb E. Brooks School of Public Policy, discusses how Cornell is helping to keep the semiconductor supply chain safe.
A party in the Temple of Zeus for retiring Zeus manager, Lydia Dutton. Left to right: A.R. Ammons, Cecil Giscombe, Dutton, David Burak, Phyllis Janowitz, James McConkey and Tony Caputi.
